Evidence map›Paper›PMID 39635731›Full record

ArticleEmerging microbes & infections2025

Nationwide seroprevalence of SARS-CoV-2 Delta variant and five Omicron sublineages in companion cats and dogs in the USA: insights into their role in COVID-19 epidemiology.

Subarna Barua, Nneka Vivian Iduu, Daniel Felipe Barrantes Murillo, Asfiha Tarannum, Hill Dimino, Suchita Barua, Yue Shu, Calvin Johnson, Megan R Miller, Kelly Chenoweth and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Emerging microbes & infections, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Subarna BaruaDepartment of Pathobiology, College of Veterinary Medicine, Auburn University, Auburn, AL, USA.
Nneka Vivian IduuDepartment of Pathobiology, College of Veterinary Medicine, Auburn University, Auburn, AL, USA.
Daniel Felipe Barrantes MurilloDepartment of Pathobiology, College of Veterinary Medicine, Auburn University, Auburn, AL, USA.
Asfiha TarannumDepartment of Pathobiology, College of Veterinary Medicine, Auburn University, Auburn, AL, USA.
Hill DiminoCollege of Sciences and Mathematics, Auburn University, Auburn, AL, USA.
Suchita BaruaCollege of Sciences and Mathematics, Auburn University, Auburn, AL, USA.
Yue ShuCollege of Sciences and Mathematics, Auburn University, Auburn, AL, USA.
Calvin JohnsonDepartment of Pathobiology, College of Veterinary Medicine, Auburn University, Auburn, AL, USA.
Megan R MillerCenter for Veterinary Medicine, U.S. Food and Drug Administration, Laurel, MD, USA.
Kelly ChenowethDepartment of Pathobiology, College of Veterinary Medicine, Auburn University, Auburn, AL, USA.
Peter ChristophersonDepartment of Pathobiology, College of Veterinary Medicine, Auburn University, Auburn, AL, USA.
Laura HuberDepartment of Pathobiology, College of Veterinary Medicine, Auburn University, Auburn, AL, USA.
Theresa WoodDepartment of Pathobiology, College of Veterinary Medicine, Auburn University, Auburn, AL, USA.
Kelley TurnerDepartment of Pathobiology, College of Veterinary Medicine, Auburn University, Auburn, AL, USA.
Chengming WangDepartment of Pathobiology, College of Veterinary Medicine, Auburn University, Auburn, AL, USA.ORCID 0000-0001-7874-8340

Funding

FDA HHS U18 FD008031
6 · The paper itself

Abstract

Understanding SARS-CoV-2 epidemiology in companion animals is critical for evaluating their role in viral transmission and their potential as sentinels for human infections. This large-scale serosurvey analyzed serum samples from 706 cats and 2,396 dogs collected across the USA in 2023 using a surrogate virus neutralization test (sVNT) to detect SARS-CoV-2 antibodies. Overall, 5.7% of cats and 4.7% of dogs tested positive for antibodies, with younger animals (under 12 months) showing significantly lower seropositivity rates (

Indexed as

Antibodies, ViralCat DiseasesCOVID-19Dog DiseasesSARS-CoV-2AnimalsAntibodies, NeutralizingCatsDogsFemaleHumansMalePetsSeroepidemiologic StudiesUnited StatesAntibodies, NeutralizingAntibodies, Viralcats and dogsDelta variantOmicron sublineagesSARS-CoV-2surrogate virus neutralization testUSA

Identifiers

PMID39635731
PMCPMC11636146

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.